Sort by
Refine Your Search
-
pioneering the development of neural stem cell (NSC) and extracellular vesicle (EV)-based therapies for neurodegenerative conditions, including traumatic brain injury (TBI), chemotherapy-related cognitive
-
Epigenetics, Epigenetics Regulation, Cancer Metabolism, Immunology, Drug Discovery, Development, and Structural Biology, with an emphasis on RNA epigenetics/epitranscriptomics (RNA modifications) and RNA-based
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies
-
top journals such as Journal of Hematology & Oncology (2024), Cancer Research (2024), Cell (2023), Cell Stem Cell (2023 ×2), and Nature Cell Biology (2022). The Su research program is currently
-
. The research program embraces team science drawing from i.e., implementation science, data science, geospatial, epidemiological, and machine learning approaches to better understand broad contexts including
-
: · Develop and maintain clinical and translational research trials in genitourinary cancers. · Collect, analyze, and maintain large databases pertaining to genitourinary cancers. · Draft
-
to vaccine development utilizing viral vectors to contribute to an effort in developing neoantigen expressing vaccines for clinical investigations. The position is available as part of a multi-disciplinary
-
pharmacology tools to identify novel signaling pathways in metabolism to develop new targets for drug discovery. Our research interests include: 1) Liver-gut and microbiota crosstalk as metabolic mediators in
-
drive our multiomics, high-throughput sequencing projects and help develop any projects based on the most advanced technologies. Your qualifications should include: Ph.D. in Biochemistry, Bioinformatics
-
laboratory focuses on developing physics-based computational methods to study protein structure, dynamics, and drug design. For more information about Dr. Vaidehi’s lab, please visit here. As a successful